Navigation Links
Pharmasset Announces Two-for-One Forward Stock Split
Date:8/9/2011

PRINCETON, N.J., Aug. 9, 2011 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS) announces that its Board of Directors declared a two-for-one split of Pharmasset's common stock, par value $0.001 per share, in the form of a 100% common stock dividend.  Stockholders of record as of the close of business on August 22, 2011 will receive one additional share of common stock for each share then owned.  The distribution date for the new shares will be August 31, 2011.  There are currently approximately 37.7 million shares of common stock outstanding.  Upon completion of the stock split, there will be approximately 75.4 million shares of common stock outstanding.

About Pharmasset

Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections.  Pharmasset's primary focus is the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection.  Our research and development efforts are focused on nucleoside/tide analogs, a class of compounds which act as alternative substrates for the viral polymerase, thus inhibiting viral replication.  We currently have three clinical-stage product candidates advancing in trials in various populations.  Our pyrimidine, PSI-7977, an unpartnered uracil nucleotide analog, is currently under study in four Phase 2b trials in patients with HCV genotypes 1 through 6, including abbreviated duration interferon and interferon-free regimens.  Our purine, PSI-938, an unpartnered guanosine nucleotide analog, reported safety and efficacy data from 14 days of monotherapy as well as 14 days in combination with the pyrimidine, PSI-7977.  An SVR-endpoint study of the purine-pyrimidine combination is anticipated to begin in the third calendar quarter of 2011.  Mericitabine (RG7128) continues in th
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
2. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
3. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
4. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
5. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
6. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
7. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
8. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
9. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
10. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
11. Pharmasset Receives Notice of Allowance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... PLAINFIELD, N.J. , July 24, 2014  PTC ... that the Company will host a webcast conference call ... provide an update on the company,s business and outlook ... before the opening of the market. ... (domestic) or (973) 935-8152 (international) five minutes prior to ...
(Date:7/24/2014)... 2014  Uroplasty, Inc. (NASDAQ: UPI ), ... markets innovative proprietary products to treat voiding dysfunctions, ... first quarter ended June 30, 2014.  Global ... System grew 19% to $4.1 million, as compared ... the prior year.  Total revenue for the fiscal ...
(Date:7/24/2014)... Calif. , July 24, 2014 Amgen (NASDAQ: ... its second quarter financial results on Tuesday, July 29, 2014, ... will be followed by a conference call with the investment ... Amgen will be Robert A. Bradway , chairman and ... team. Live audio of the conference call will ...
Breaking Medicine Technology:Uroplasty Reports Fiscal First Quarter Results 2Uroplasty Reports Fiscal First Quarter Results 3Uroplasty Reports Fiscal First Quarter Results 4Uroplasty Reports Fiscal First Quarter Results 5Uroplasty Reports Fiscal First Quarter Results 6Uroplasty Reports Fiscal First Quarter Results 7Uroplasty Reports Fiscal First Quarter Results 8Uroplasty Reports Fiscal First Quarter Results 9Uroplasty Reports Fiscal First Quarter Results 10Uroplasty Reports Fiscal First Quarter Results 11Amgen Announces Webcast of 2014 Second Quarter Financial Results 2
(Date:7/26/2014)... July 26, 2014 Recently, iFitDress.com, a ... for women, has unveiled its new range of high ... offer on the brand new items; they are now ... , iFitDress.com is one of the leading suppliers ... officer, all the wholesale party dresses have ...
(Date:7/26/2014)... Dallas,Texas (PRWEB) July 26, 2014 “BRIC ... on the BRIC Sinuscopes market. The report provides value, ... average prices (in US dollars) within market segments – ... shares and distribution shares data for each of these ... market participants, pipeline products, and news and deals related ...
(Date:7/26/2014)... TX (PRWEB) July 26, 2014 ... or encephalomyelitis disseminata, is an inflammatory disease in ... the brain and spinal cord are damaged. This ... nervous system to communicate, resulting in a wide ... and sometimes psychiatric problems. Multiple sclerosis takes several ...
(Date:7/26/2014)... Seattle, Wa (PRWEB) July 26, 2014 ... updated by Vkool.com, this is a comprehensive bodybuilding program ... simultaneously without using anabolic steroids . The program ... lean muscle without cardio. , Vkool reveals in ... exercises and workouts that can help men get ripped ...
(Date:7/25/2014)... Dental Perfection, a Derby cosmetic dentist ... general dentistry, clear braces and much more, has just ... in Derby. The new practice, which is scheduled to ... in Littleover, Derby. Patients may already pre-register for the ... dental practice, which is headed by Invisalign specialist and ...
Breaking Medicine News(10 mins):Health News:High Quality Wholesale Party Dresses Online at iFitDress.com 2Health News:Sinuscopes Market in BRIC (Brazil, Russia, India & China) Forecast to 2020 Report Available at MarketOptimizer.org 2Health News:Sinuscopes Market in BRIC (Brazil, Russia, India & China) Forecast to 2020 Report Available at MarketOptimizer.org 3Health News:Sinuscopes Market in BRIC (Brazil, Russia, India & China) Forecast to 2020 Report Available at MarketOptimizer.org 4Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 2Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 3Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 4Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 2Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 3Health News:Derby Cosmetic Dentist Dental Perfection to Open New Practice in Littleover, Derby this September 2
... in small study took capsules equivalent to brewed beverage, , ... green tea might slow the progression of prostate cancer, the ... 26 men, 41 to 72 years old, who had prostate ... took four capsules a day of an investigational agent called ...
... , Local Vascular Surgeon Named National Principal Investigator , ... from Arizona Heart Institute performed the first procedure in ... Vascutek Anaconda Stent Graft System , an investigational, minimally ... , Leading the study efforts in the U.S. ...
... , DEERFIELD BEACH, Fla., June 19 Sentry Data ... scanning device, Sentinel Mobile Manager(TM), as part of ... feedback and the desire to provide increased value ... with Sentinel RCM,s(TM) core functionality and provides a ...
... BEIJING, June 19 /PRNewswire-Asia-FirstCall/ -- China ... a leading China-based medical device,company that develops, manufactures and ... financial results for,the fourth fiscal quarter (,4Q FY2008,) and ... 2009 (,FY2008,). The Company,s 2008 fiscal year ends ...
... ... readers, AmericanHealthandBeauty.com has added Dysport, formerly known as Reloxin, as a procedure on their website. ... Houston, TX (PRWEB) June ... lines and wrinkles on the face, has recently gained FDA approval and is expected to ...
... (NYSE: SRZ ) today announced that it will transition ... As previously disclosed in its 2008 10-K, Sunrise could be terminated ... to comply with their financial covenants in 2008. HCP announced ... , "While we regret the loss of these communities, it ...
Cached Medicine News:Health News:Green Tea Component May Slow Prostate Cancer 2Health News:Arizona Heart Institute Enrolls First Patient in Anaconda(TM) Investigational Study for the Treatment of Abdominal Aortic Aneurysm 2Health News:Arizona Heart Institute Enrolls First Patient in Anaconda(TM) Investigational Study for the Treatment of Abdominal Aortic Aneurysm 3Health News:Sentry Data Systems, Inc. Announces: Sentinel RCM(TM) - Now with Mobile Manager(TM) Included! 2Health News:China Medical Technologies Announces Selected Unaudited Preliminary Financial Results for the Fourth Fiscal Quarter and Full Year Ended March 31, 2009 2Health News:China Medical Technologies Announces Selected Unaudited Preliminary Financial Results for the Fourth Fiscal Quarter and Full Year Ended March 31, 2009 3Health News:Dysport Added as a Procedure on AmericanHealthandBeauty.com: Let the Wrinkle Wars Begin 2Health News:Dysport Added as a Procedure on AmericanHealthandBeauty.com: Let the Wrinkle Wars Begin 3
... Tissue transglutaminase (tTg) is a ... of proteins. Tissue transglutaminase is also ... by the endomysial antibody immunofluorescence (EMA) ... 29060). Anti-tTg IgA and IgG serologic ...
... training it needs with the NetLearning Management ... Capital Management System in one. Whether it ... and HIPAA, understanding compliance reporting for OSHA, ... through continuing education courses, the NetLearning system ...
We offer small and large pre-gelled Surface Electrodes suitable for EMG or EGG recordings....
We offer small and large pre-gelled Surface Electrodes suitable for EGG or EMG recordings. Surface Electrodes, Skin Preparation and Conductive Cream complete the setup for a EGG study and are essenti...
Medicine Products: